000 01191 a2200361 4500
005 20250517141658.0
264 0 _c20180207
008 201802s 0 0 eng d
022 _a1872-8278
024 7 _a10.1016/j.mito.2017.02.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShi, Xianxun
245 0 0 _aIntravenous administration of mitochondria for treating experimental Parkinson's disease.
_h[electronic resource]
260 _bMitochondrion
_c05 2017
300 _a91-100 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravenous
650 0 4 _aAnimals
650 0 4 _aBiological Products
_xadministration & dosage
650 0 4 _aCell Line
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMitochondria
650 0 4 _aParkinson Disease
_xtherapy
650 0 4 _aTreatment Outcome
700 1 _aZhao, Ming
700 1 _aFu, Chen
700 1 _aFu, Ailing
773 0 _tMitochondrion
_gvol. 34
_gp. 91-100
856 4 0 _uhttps://doi.org/10.1016/j.mito.2017.02.005
_zAvailable from publisher's website
999 _c26918695
_d26918695